Cellectar Biosciences, Inc. Resources

Patients News & Media Investors Contact

Cellectar Biosciences, Inc.

  • Home
  • About
    • Overview
    • Partnerships
    • Management Team
    • Board of Directors
  • Platform
    • Overview
    • Posters & Publications
  • Product Pipeline
    • Overview
    • Iopofosine
  • Clinical Studies
    • Overview
    • Waldenstrom’s Macroglobulinemia Phase 2 Study Active, not recruiting
    • Relapsed or Refractory Select B-Cell Malignancies Clinical Study Active, not recruiting
    • Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG Active, not recruiting
  • Patients
  • News & Media
  • Investors
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events

Cellectar Biosciences Reports First Quarter 2015 Financial Results and Provides Update on Clinical Programs

May 21, 2015

Cellectar Biosciences to Host Conference Call on May 21st to Discuss First Quarter 2015 Results and Provide Update on Development Programs

May 20, 2015

Cellectar Biosciences Reschedules Release of First Quarter Financials and Quarterly Conference Call

May 11, 2015

Cellectar Biosciences to Host Conference Call on May 12th to Discuss First Quarter 2015 Results and Provide Update on Development Programs

May 5, 2015

Cellectar Biosciences Initiates Proof-of-Concept Trial of I-131-CLR1404 in Multiple Myeloma

Apr 15, 2015

Cellectar Biosciences Full-Year 2014 Financial Results and Recent Highlights

Mar 24, 2015

Cellectar Biosciences to Host Conference Call on March 24th to Discuss Fourth Quarter and Full Year 2014 Results and Provide Update on Development Progress

Mar 17, 2015

Cellectar Biosciences to Present at 27th Annual Roth Conference

Mar 4, 2015

Cellectar Biosciences to Present at the 17th Annual BIO CEO & Investor Conference 2015

Feb 6, 2015

Peer-Reviewed Glioma Surgery Study With Cellectar Biosciences Fluorescence Cancer-Targeting Agents Chosen for the Cover of Neurosurgery

Jan 22, 2015
    • 1...
    • 27
    • 28
    • 29
    • 30
    • 31
    • 32
    • 33
    • 34
    • 35
    • 36
    © 2025 Cellectar Biosciences, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap Q&A